Insurer Need Not Cover Parkinson's Drug Antitrust Dispute
By Gianna Ferrarin · March 25, 2026, 3:09 PM EDT
An insurer does not owe coverage in an antitrust suit accusing a pharmaceutical company of suppressing generic versions of the Parkinson's treatment Apokyn, a Maryland federal judge ruled, finding the dispute...
To view the full article, register now.